Together with our sponsor, Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, we are delighted to announce our fourth Researcher Insights report for the autumn of 2023: with focus on cell and gene therapy.
.png?width=500&height=167&name=RI%20-%20CGT%20Email%20Header%20(2).png)
Cell and gene therapy has made remarkable progress in recent decades. Thanks to advancements in technology, scientists can now explore new frontiers in studying and treating some of the most challenging afflictions of our time: either by targeting disease-causing mutations in the genome (e.g. in Huntington's disease and cystic fibrosis), or using specially grown cells to regenerate tissues and fight inflammation in cancer, heart disease, even obesity). In this issue, we’ll hear about some of the latest breakthroughs in the field and talk directly to researchers about their work. In a special feature article, we’ll also hear from ACD about their latest products, their outlook on the field and what makes their brand stand out from competitors.
Register here to receive your free copy and discover recent scientific findings, highlights and insights from the industry.
Meet the independent experts we spoke to for this issue:
- Dr Edith Pfister, University of Massachusetts
- Dr Fatima A. Saleh, Beirut Arab University
- Prof Kevin Morris, Griffith University
- Ms Nikki Reyne, The University of Adelaide
- Dr Kelly Banas, ChristianaCare
- Dr Eric B. Kmiec, ChristianaCare
This editorially independent report is produced in association with ACD. Unless otherwise stated, the contributors in this issue do not endorse or sponsor any commercial product, service, or activity illustrated by third-party information and/or content.
For more information about this issue of Researcher Insights, please click here.
About Researcher Insights
Researcher Insights is a brand new concept by Researcher created for academics and industrial leaders to spotlight leading trends, insights and analyses in science. We will be speaking to a range of experts to learn about their current and future work, developments in technology and the novel practices which are inspiring innovation.
About Researcher
Researcher is a content discovery and discussion app with over 20,000 content sources and 2.5 million users in the scientific and research communities. Researcher is a Blenheim Chalcot Company. Blenheim Chalcot is the UK's leading venture builder with portfolio sales of over £300 million, over 3,000 employees and a successful track record of over 40 companies.
Media Contact
Trisa Triandesa Tjahyaman, Marketing Coordinator
